Compounds > tetrabenazine
Page last updated: 2024-08-17

tetrabenazine and Agitation, Psychomotor

tetrabenazine has been researched along with Agitation, Psychomotor in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kertesz, DP; Maze, D1
Armangue, T; Cantarín-Extremera, V; Duat-Rodríguez, A; González-Gutiérrez-Solana, L; López-Marín, L1
Davidson, A; Hunter, C; Jankovic, J; Jimenez-Shahed, J; Mehanna, R1
Fahn, S1

Trials

1 trial(s) available for tetrabenazine and Agitation, Psychomotor

ArticleYear
Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
    Neurology, 2006, Feb-14, Volume: 66, Issue:3

    Topics: Accidental Falls; Anti-Dyskinesia Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Huntington Disease; Psychomotor Agitation; Suicide; Tetrabenazine; Treatment Outcome

2006

Other Studies

4 other study(ies) available for tetrabenazine and Agitation, Psychomotor

ArticleYear
Isolated vocal akathisia-Does it exist?
    Asian journal of psychiatry, 2018, Volume: 36

    Topics: Adrenergic Uptake Inhibitors; Aged, 80 and over; Female; Humans; Psychomotor Agitation; Tetrabenazine; Tics

2018
Clinical case of anti-N-methyl-D-aspartate receptor encephalitis in an 8-month-old patient with hyperkinetic movement disorder.
    Pediatric neurology, 2013, Volume: 48, Issue:5

    Topics: Anti-Dyskinesia Agents; Anti-Inflammatory Agents; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Deglutition Disorders; Humans; Hyperkinesis; Immunoglobulins, Intravenous; Infant; Male; Methylprednisolone; Movement Disorders; Prednisone; Psychomotor Agitation; Stupor; Tetrabenazine; Treatment Outcome

2013
Analysis of CYP2D6 genotype and response to tetrabenazine.
    Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:2

    Topics: Adult; Anti-Dyskinesia Agents; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Huntington Disease; Hyperkinesis; Male; Middle Aged; Movement Disorders; Myoclonus; Pharmacogenetics; Phenotype; Psychomotor Agitation; Tetrabenazine; Tourette Syndrome; Treatment Outcome

2013
A therapeutic approach to tardive dyskinesia.
    The Journal of clinical psychiatry, 1985, Volume: 46, Issue:4 Pt 2

    Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Colitis; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyltyrosines; Middle Aged; Nausea; Paranoid Disorders; Psychomotor Agitation; Psychoses, Substance-Induced; Psychotic Disorders; Receptors, Dopamine; Reserpine; Tetrabenazine; Time Factors

1985